ANGPT2 and Venous thrombosis: Furthermore, we found that either over-expressing tumour necrosis factor alpha (TNF-α) or blocking soluble TNF receptor (sTNF-R) could lead to a reduction of both of the organ dysfunction endpoints (Ang2 and Thrombosis).